AGP Executive Report
Last update: 16 minutes agoMental Health Breakthrough: Compass Pathways reported 26-week Phase 3 results for COMP360 (synthetic psilocybin) in treatment-resistant depression, showing rapid onset and a durable response in nearly 600 patients. Cancer Care & Symptom Relief: A UCSF oncologist discussed vasomotor symptoms in breast cancer, including how past trials tested both natural options and standard meds—while noting placebo effects can still reduce hot flashes. Women’s Health: A new look at menopause highlights why symptoms vary by country, shaped by stigma, access to care, and lifestyle. Pain Research: Johns Hopkins-linked work in mice points to parathyroid hormone as a potential root-cause target for chronic back pain. Traditional Medicine Science: Nagaland’s International University launched a project to document, chemically map, and clinically standardize Naga ethnomedicine to protect indigenous knowledge and support safer integration. Wellness Market Watch: A report projects the global herbal beauty products market could reach $173.47B by 2034, driven by a 7.45% CAGR. Local Integrative Care: Austin’s Oak Haven Massage promoted orthopedic and oncology massage services, including somatic release for stress and anxiety and specialized care for cancer patients.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.